Gerdau S.A.:戦略・SWOT・企業財務分析

◆英語タイトル:Gerdau S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015554
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Gerdau S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Gerdau S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Gerdau S.A. (Gerdau or ‘the company’) is engaged in the production of steel products. The company operates in the Americas, Europe, and Asia. It is headquartered in Rio Grande do Sul, Brazil and employed 40,061 people as on December 31, 2014.

Scope

- Detailed information on Gerdau S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Gerdau S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Gerdau S.A. including a breakdown and examination of key business segments
- Intelligence on Gerdau S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Gerdau S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Gerdau S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Gerdau S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Gerdau S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Gerdau S.A.: Company Overview
Gerdau S.A.: Overview and Key Facts
Gerdau S.A.: Overview
Gerdau S.A.: Key Facts
Gerdau S.A.: Key Employees
Gerdau S.A.: Key Employee Biographies
Gerdau S.A.: Major Products and Services
Gerdau S.A.: Company History
Gerdau S.A.: Management Statement
Gerdau S.A.: Locations and Subsidiaries
Gerdau S.A.: Key Competitors
Gerdau S.A.: Company Analysis
Gerdau S.A.: Business Description
Gerdau S.A.: SWOT Analysis
Gerdau S.A.: SWOT Overview
Gerdau S.A.: Strengths
Gerdau S.A.: Weaknesses
Gerdau S.A.: Opportunities
Gerdau S.A.: Threats
Gerdau S.A.: Corporate Financial Deals Activity
Gerdau S.A.: Financial Deals Overview
Gerdau S.A.: Targets and Partners
Gerdau S.A.: Top Deals 2013 – 2017YTD*
Gerdau S.A.: Advisors
Gerdau S.A.: Top Legal Advisors
Gerdau S.A.: Mergers and Acquisitions
Gerdau S.A.: Partnership
Gerdau S.A.: Divestments
Gerdau S.A.: Recent Developments
Gerdau S.A.: News and Events Summary
Gerdau S.A.: Contracts
Gerdau S.A.: Financial Performance
Gerdau S.A.: Red Flags/DistressSignals
Gerdau S.A.: Regulatory and Legal Events
Gerdau S.A.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Gerdau S.A.: Key Facts
Table 2: Gerdau S.A.: Key Employees
Table 3: Gerdau S.A.: Locations and Subsidiaries
Table 4: Gerdau S.A.: Key Competitors
Table 5: Gerdau S.A.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Gerdau S.A.: M&A Average Deal Size - Value (US$m)
Table 7: Gerdau S.A.: Targets and Partners
Table 8: Gerdau S.A.: Top Deals 2013 - 2017YTD*
Table 9: Gerdau S.A.: Legal Advisor Ranking by Value (US$m)
Table 10: Gerdau S.A.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 11: Gerdau S.A.: M&A Activity by Geography (2013 - YTD*2017)
Table 12: Gerdau S.A.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 13: Gerdau S.A.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 14: Gerdau S.A.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 15: Gerdau S.A.: Divestments by Geography (2013 - YTD*2017)
Table 16: Gerdau S.A.: News and Events Summary
Table 17: Gerdau S.A.: Contracts
Table 18: Gerdau S.A.: Financial Performance
Table 19: Gerdau S.A.: Red Flags/DistressSignals
Table 20: Gerdau S.A.: Regulatory and Legal Events
Table 21: Gerdau S.A.: Strategy and Operations

★海外企業調査レポート[Gerdau S.A.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Damas International Ltd:企業の戦略・SWOT・財務分析
    Damas International Ltd - Strategy, SWOT and Corporate Finance Report Summary Damas International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Oncgnostics GmbH-医療機器分野:企業M&A・提携分析
    Summary Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the met …
  • Randall & Quilter Investment Holdings Ltd.:企業のM&A・事業提携・投資動向
    Randall & Quilter Investment Holdings Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Randall & Quilter Investment Holdings Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Lidds AB (LIDDS):企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Abaxis Inc:企業の戦略的SWOT分析
    Abaxis Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • United-Guardian Inc (UG):企業の財務・戦略的SWOT分析
    Summary United-Guardian Inc (United-Guardian) is a diversified company that manufactures and markets healthcare products. The company offers pharmaceuticals, cosmetic ingredients, health care products and proprietary industrial products, among others. It provides medical devices such as lubrajel flu …
  • Hologic Inc (HOLX)-製薬・医療分野:企業M&A・提携分析
    Summary Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of …
  • Mediaset S.p.A. (MS):企業の財務・戦略的SWOT分析
    Mediaset S.p.A. (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Brainsway Ltd (BRIN):企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Immatics Biotechnologies GmbH:企業のM&A・事業提携・投資動向
    Immatics Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Immatics Biotechnologies GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Sorrento Therapeutics Inc (SRNE):製薬・医療:M&Aディール及び事業提携情報
    Summary Sorrento Therapeutics Inc (STI), formerly QuikByte Software Inc, is a cancer therapeutic service provider. The company offers CD38 CAR-T, lidocaine topical system, resiniferatoxin. Its product pipeline includes CD38 CAR-T, CEA CAR-T, CD38 ADC and seprehvir. STI provides treatment for multipl …
  • American Axle & Manufacturing Holdings, Inc.:企業の戦略・SWOT・財務情報
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Ultragenyx Pharmaceutical Inc (RARE):医療機器:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • Celldex Therapeutics Inc (CLDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops and commercializes targeted immunotherapy technologies and cancer-targeting biologicsfor the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodie …
  • Israel Corporation Limited:企業のM&A・事業提携・投資動向
    Israel Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Israel Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Cerus Corp (CERS)-医療機器分野:企業M&A・提携分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • National Research Corp (NRCIB):企業の財務・戦略的SWOT分析
    Summary National Research Corp (NRC) is a healthcare organization that provides market insight solutions. The company’s solutions include experience collection, market insights, transparency of experience data and governance. It offers market insights solutions that allow the tracking of awareness, …
  • Molecular Templates Inc:企業のM&A・事業提携・投資動向
    Molecular Templates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molecular Templates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Xhale Inc:製品パイプライン分析
    Summary Xhale Inc (Xhale) is a medical technology company that develops and commercializes patient-centric monitoring solutions for the healthcare industry. The company offers platforms such as SMART and assurance platforms. Its products include therapeutic drug monitoring, metabolic pathway assessm …
  • Aqua Bio Technology ASA (ABT):企業の財務・戦略的SWOT分析
    Summary Aqua Bio Technology ASA (ABT) is a biotechnology company that develops, produces and markets new active ingredients. The company’s products comprise Aquabeautine XL and Smids. Its product Aquabeautine XL is derived from the hatching fluid of salmon. ABT’s products are based on research and d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆